Pages

• Contact Us
• Home
• Investors
• News
• Privacy Policy
• Teams
  • Advisory Board
  • Board of Directors
  • Management Team
• Technology

Posts by category

• Category: Company News and Events
  • Veralox Therapeutics Announces FDA Orphan Drug Designation for VLX-1005
  • Veralox Therapeutics Announces IND Submission for VLX-1005 to Treat Heparin-Inducted Thrombocytopenia
  • Veralox Therapeutics Appoints Life Sciences Industry Veteran Alex Martin as Chairman of the Board of Directors
  • Veralox Therapeutics Raises $5.4 Million in Seed Funding Co-Led by JDRF T1D Fund and Sanofi Ventures
  • Biotech Startups On the Rise in Frederick, Maryland
  • Frederick Innovative Technology Center, Inc. – Success Story
  • Meet Our Clients: Jeff Strovel, CEO of VERALOX Therapeutics